As obesity rates continue to rise, many are turning to prescription medicines like Ozempic for weight loss. But with ...

With abuse of weight loss drugs continuing to be an issue in Australia, researchers from the University of South Australia ...

Amgen stock tumbled Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's ...

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The rise in obesity rates across the United States has brought increased attention to treatments aimed at addressing the ...

Learn more about the metabolic effects of liraglutide treatment in individuals with type 2 diabetes and obesity.

Daewoong Pharmaceutical announced Tuesday that it has filed for a domestic patent for a new obesity drug that suppresses ...

MASLD diagnosis was associated with an increased risk for youth-onset type 2 diabetes among pediatric patients with obesity.

Congress has been considering bipartisan solutions to help address the growing obesity problem for over a decade now.

Goldman Sachs analyst Salveen Richter has maintained their bullish stance on AMGN stock, giving a Buy rating yesterday.Don't Miss our Black ...

Analyst Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) and keeping the price ...